Motivation et neurotransmetteurs chez les rameurs
Corrélats psychobiologiques de la motivation à la performance et réponses des neurotransmetteurs à l'exercice chez les rameurs d'élite
The goal of this observational study is to learn how motivation and body chemistry are linked during and after intense exercise in national-level rowers.
The main questions this study aims to answer are:
Do athletes with higher motivation show different changes in brain chemicals after exercise? How do hormone and neurotransmitter levels change during recovery after exercise?
Participants will:
Complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI) before the exercise test.
Perform a 6000-meter rowing test on an indoor rowing machine. Have blood samples taken three times: before exercise, immediately after exercise, and 1 hour after exercise.
Researchers will measure blood levels of testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG).
This study will help researchers understand how motivation and body chemistry work together to influence performance and recovery in highly trained athletes.
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Description détaillée
This study explores how motivation and body chemistry are connected during and after intense physical exercise in national-level rowers. Researchers want to understand how psychological factors, such as motivation to achieve goals, relate to changes in hormones and brain chemicals that occur with exercise and recovery.
Before the exercise test, participants will complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI). This questionnaire helps identify how strongly a person is driven to perform, overcome challenges, and reach success.
After the questionnaire, each participant will complete a 6000-meter rowing test on an indoor rowing machine. This test is designed to produce a high level of physical effort similar to competition conditions. Blood samples will be taken three times: before the test, immediately after the test, and one hour after recovery.
The blood samples will be used to measure levels of several hormones and neurotransmitters, including testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG). These substances are involved in stress response, motivation, reward, and recovery.
Researchers will compare the results from the motivation questionnaire with changes in hormone and neurotransmitter levels. The goal is to find out whether more motivated athletes show different chemical responses to exercise and recovery.
Findings from this study may improve understanding of how the mind and body interact during intense training. This knowledge could help athletes and coaches develop better ways to support motivation, performance, and recovery in high-level sports.
Type d'étude
Type d'étude
Inscription (Réel)
Inscription
Contacts et emplacements
Lieux d'étude
-
-
Greater Poland Voivodeship
-
Poznan, Greater Poland Voivodeship, Pologne, 61-871
- Poznań University of Physical Education
-
-
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
All participants were recruited and tested at the Central Sports Centre - Olympic Preparation Center (COS OPO) in Wałcz, Poland, during a national team training camp under standardized conditions.
La description
Inclusion Criteria:
National-level male rowers Age between 18 and 25 years Minimum of 3 years of systematic rowing training Regular training load (at least 10 sessions per week during the competitive season) Good general health and medical clearance for maximal exercise testing
Exclusion Criteria:
Current illness, injury, or infection Use of medications or dietary supplements that could affect hormone or neurotransmitter levels Smoking or use of psychoactive substances Inadequate sleep or food intake before testing Refusal or inability to provide informed consent
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: RETROSPECTIVE
Nombre de groupes / cohortes
Cohortes et interventions
Groupe / CohorteGroupe / Cohorte |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Rowers
The study includes 24 national-level male rowers. All participants are healthy, highly trained athletes with at least 3 years of systematic rowing experience and regular intensive training. |
Participants perform a 6000-meter rowing test on an indoor ergometer at maximal effort to simulate race conditions and induce physiological fatigue. |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in serum Cortisol levels
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Cortisol serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Testosterone levels
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Testosterone serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Dopamin levels
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Dopamin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Serotonin levels
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Serotonin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum Beta-endorphin levels
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of Beta-endorphin serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum anandamide (AEA) levels
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of anandamide (AEA) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in serum 2-arachidonoylglycerol (2-AG)) levels
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Measurement of 2-arachidonoylglycerol (2-AG) serum concentrations (ng/mL). |
Before exercise, immediately after, and 1 hour after recovery
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in Testosterone-to-cortisol ratio (T:C)
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Ratio calculated from serum testosterone and cortisol concentrations (ng/mL), used as an indicator of anabolic-catabolic balance. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Changes in TSerotonin-to-dopamine ratio (S:D)
Délai: Before exercise, immediately after, and 1 hour after recovery
|
Ratio of serum serotonin to dopamine concentrations (ng/mL), reflecting neurochemical balance related to motivation and fatigue. |
Before exercise, immediately after, and 1 hour after recovery
|
|
Achievement Motivation (LMI score)
Délai: Before exercise (baseline)
|
Assessment of achievement motivation using the Inventory of Achievement Motivation (LMI). The questionnaire evaluates multiple dimensions of motivation, such as persistence, confidence in success, goal setting, and compensatory effort. Total and subscale scores are analyzed to identify individual motivational profiles. |
Before exercise (baseline)
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Début de l'étude
Achèvement primaire (Réel)
Achèvement primaire
Achèvement de l'étude (Réel)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- LMI60002023
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Individual participant data (IPD) will not be shared. Data will be used only for internal analysis and dissemination in scientific publications in aggregate form, in accordance with ethical approval.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .